Halozyme Therapeutics HALO is scheduled to report fourth-quarter and full-year 2024 results on Feb. 18, after market close. The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is ...

Pagaya Technologies delivered impressive fourth-quarter results, surpassing analysts' estimates on multiple metrics.

Colgate-Palmolive Company CL delivered mixed results for fourth-quarter 2024. While the company's earnings exceeded the Zacks Consensus Estimate, its revenues fell short of expectations. Despite the ...

Today, majors across segments including Godfrey Phillips, United Breweries, Senco Gold, Reliance Infra, Hindalco, Healthcare ...

Crocs-branded footwear is expected to grow 4.5% in 2025, but sales of its smaller HeyDude line could be down as much as 9%.

LiveOne Inc (NASDAQ:LVO) is set to release its Q3 2025 earnings on Feb 14, 2025. The consensus estimate for Q3 2025 revenue ...

Crocs Inc.'s stock was up nearly 16% in premarket trading on Thursday after the footwear maker's outlook for adjusted 2025 profit came in ahead of Wall Street analyst estimates. Crocs (CROX) said it ...

XPeng could have a breakout year, as it is gearing up for approximately 72% sales growth, in a base-case scenario. Read why I ...

Dow, S&P 500, and Nasdaq futures are falling in premarket trading Thursday as the stock market reacts to CPI inflation data and President Donald Trump's Russia-Ukraine peace talks.

French industrial group Legrand guided on Thursday for full-year 2025 organic sales growth of 6% to 10%, prompting its shares ...

The gain, led by agricultural products such as rice, was bigger than the consensus estimate of 4% and compared with a revised ...

Robinhood shares surged as its Q4 results beat consensus estimates. Net income reached $916 million while crypto revenue ...